Lovastatin Therapy for X-Linked Adrenoleukodystrophy: Clinical and Biochemical Observations on 12 Patients
- 1 April 2000
- journal article
- clinical trial
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 69 (4) , 312-322
- https://doi.org/10.1006/mgme.2000.2977
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Tumor necrosis factor-α and X-linked adrenoleukodystrophyJournal of Neuroimmunology, 1995
- Adrenoleukodystrophy: The Restoration of Peroxisomal β-Oxidaton by Transfection of Normal cDNABiochemical and Biophysical Research Communications, 1995
- Clinical variation in X-linked adrenoleukodystrophy: Fatty acid and lipid metabolism in cultured fibroblastsBiochemical Medicine and Metabolic Biology, 1991
- Direct demonstration that the deficient oxidation of very long chain fatty acids in X-linked adrenoleukodystrophy is due to an impaired ability of peroxisomes to activate very long chain fatty acidsBiochemical and Biophysical Research Communications, 1988
- Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro.Journal of Clinical Investigation, 1988
- Lignoceroyl‐CoASH ligase: enzyme defect in fatty acid β‐oxidation system in X‐linked childhood adrenoleukodystrophyFEBS Letters, 1986
- Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophyAnnals of Neurology, 1985
- Rating neurologic impairment in multiple sclerosisNeurology, 1983
- Myelin Membrane from Adrenoleukodystrophy Brain White Matter—Biochemical PropertiesJournal of Neurochemistry, 1983
- Qualitative alteration in substrate specificity of mitochondrial monoamine oxidase in brainJournal of Neurochemistry, 1976